Spontaneous Death of Echinococcus multilocularis: Cases Diagnosed Serologically (by Em2 Elisa) and Clinical Significance

R. L. RauschDivision of Animal Medicine SB-42, School of Medicine, University of Washington, Seattle, Washington 98195

Search for other papers by R. L. Rausch in
Current site
Google Scholar
PubMed
Close
,
J. F. WilsonDepartments of Surgery and Medicine, Alaska Native Medical Center, P.O. Box 7-741, Anchorage, Alaska 99510

Search for other papers by J. F. Wilson in
Current site
Google Scholar
PubMed
Close
,
P. M. SchantzHelminthic Diseases Branch, Division of Parasitic Diseases, Centers for Disease Control, Atlanta, Georgia 30333

Search for other papers by P. M. Schantz in
Current site
Google Scholar
PubMed
Close
, and
B. J. McMahonDepartments of Surgery and Medicine, Alaska Native Medical Center, P.O. Box 7-741, Anchorage, Alaska 99510

Search for other papers by B. J. McMahon in
Current site
Google Scholar
PubMed
Close
View More View Less
Restricted access

Nine cases of asymptomatic alveolar hydatid disease (AHD) of the liver were diagnosed in 1985 among Eskimos from the endemic region of western Alaska. The patients were identified by screening with the enzyme-linked immunosorbent assay, using purified Echinococcus multilocularis antigen (Em2 ELISA). Five patients, and one diagnosed earlier (1979), were found to have lesions in which the larval E. multilocularis had died spontaneously at an early stage of infection. Viability was assessed histologically; by the avidinbiotin immunohistochemical method; and in vivo through intraperitoneal inoculation of membranes of the larval cestode into red-backed voles, Clethrionomys rutilus. The results were in agreement with the clinical impression, based on findings by computerized tomography and ultrasound scanning, and on the macroscopic appearance of the lesions, that the cestode was dead. Spontaneous death of E. multilocularis in humans has not been previously reported. The findings show that the Em2 ELISA may be positive in patients having lesions of AHD in which the etiologic agent is no longer viable.

Save